Director, Medical Science Liaison (Dallas, AR, LA, OK, MS)
Company websiterevmed.com (Revolution Medicines, opens in new tab)
Base salary $236K to $259K
Employer-published annual base salary, USD. Advertised base range in United States
You apply on the employer's own site. Six Figure Work does not handle applications.
- LocationUnited States
- WorkplaceWorkplace not stated
- Status at last checkSource accepting applications when checked
- Last checked (1 h ago) · observed since
About this job
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses.
Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator.
This role covers Dallas, Arkansas, Louisiana, Oklahoma and Mississippi. The candidate should be located within an hour drive of a major airport.
-
Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge.
-
Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions.
-
Support the synthesis and communicate scientific insights from KOLs to relevant internal teams.
-
Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities.
-
Establish credibility as a scientific expert and resource for internal stake holders, providing medical and scientific support for products and therapeutic areas.
-
Collaborate cross-functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics.
-
Stay current with scientific literature, emerging research, and competitive landscape.
-
Adhere to Revolution Medicines Core Values and policies.
-
Understand the regulatory requirements for customer engagement by field-based employees.
Required Skills, Experience and Education:
-
Doctoral degree in scientific or medical discipline.
-
8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry.
-
3+ years experience as a MSL working in the lung cancer disease state area.
-
Strong understanding of clinical research methodologies and drug development processes.
-
Knowledge and experience within the oncology therapeutic area.
-
Excellent verbal and written communication skills.
-
Proven ability to analyze and synthesize scientific information effectively.
-
Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences.
-
Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals.
-
Self-directed and able to thrive in a fast-paced and dynamic environment.
-
Willingness to travel up to 60% of time.
Preferred Skills:
-
Preferred experience in lung and gastrointestinal cancers.
-
Experience with both early and late stage clinical assets as well as approved therapies.
#LI-Remote #LI-VN1
The base pay salary range for this full-time position is listed below. Please note that base pay salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. In addition, some positions may include eligibility to earn commissions/bonus based on company and/or individual performance.
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, field kit benefits, or any other form of compensation and field kit benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
Base Pay Salary Range
$236,000—$259,000 USD
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Source: Revolution Medicines on Greenhouse · View original posting (opens in new tab)
Pay in context
This role's base floor ($236,000) is above 92% of the 1,811 Science & Research roles nationwide listed on this site; 1 other lists the same floor. Their median floor is $153,000; the middle half runs from $124,714 to $180,615.
Only jobs on this site count, and each one publishes a base salary of $100,000 or more, so this compares six-figure jobs with each other, not with the whole market. Computed Nov 8, 2026.
This listingDirector, Medical Science Liaison (Dallas, AR, LA, OK, MS)$236K to $259K
Senior Director, Global People Operations$232K to $290K
Senior Director, Global Pricing Execution$232K to $290K
Senior Director, HEOR/RWE - GI$232K to $290K
Senior Director, Global Commercial Development, Early Detection & Market Shaping$232K to $290K
Senior Director, US Medical Affairs Strategy Lead, Gastrointestinal, Oncology and Emerging Indications$232K to $290K
Senior Director, Commercialization FP&A$232K to $290K
Chart as a table
| Role | Published base |
|---|---|
| Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) (this listing) | $236K - $259K |
| Senior Director, Global People Operations | $232K - $290K |
| Senior Director, Global Pricing Execution | $232K - $290K |
| Senior Director, HEOR/RWE - GI | $232K - $290K |
| Senior Director, Global Commercial Development, Early Detection & Market Shaping | $232K - $290K |
| Senior Director, US Medical Affairs Strategy Lead, Gastrointestinal, Oncology and Emerging Indications | $232K - $290K |
| Senior Director, Commercialization FP&A | $232K - $290K |
Observed changes
- Began meeting the published-salary criteria
- First observed on the employer's board
- Observed since
- Employer-stated posting date
- 2026-05-19
Where this pay comes from
Location as the employer wrote it: Remote (United States)
USD 236,000 – 259,000 · interval unstated · pay_input_range · Base Pay Salary Range · base-labelled (R1: Base Pay)
- Method
- Structured pay field published by the employer
- Checked
- Rule set
- us-base-v2
The employer's job board publishes this pay as a dedicated data field. We read the field directly; no interpretation was needed.
What we verified
- The pay figures come from the employer's own listing, quoted exactly above.
- The pay is an annual base salary in US dollars with a minimum of at least $100,000.
- The role was publicly listed on the employer's job board when last checked.
We do not verify what the employer will actually offer, whether the employer is still recruiting for the role, or anything beyond what the employer published. Full methodology.
